No Data
No Data
Stereotaxis to Present at Upcoming Investor Conferences
Stereotaxis Robotic Technology to Be Featured During Heart Rhythm Society's HRX Congress
Express News | Stereotaxis Inc Files for Resale of up to 6.1 Mln Common Shares by the Selling Stockholder - SEC Filing
Lake Street Maintains Stereotaxis(STXS.US) With Buy Rating, Maintains Target Price $4
Lake Street analyst Frank Takkinen maintains $Stereotaxis(STXS.US)$ with a buy rating, and maintains the target price at $4.According to TipRanks data, the analyst has a success rate of 42.3% and a
Lake Street Keeps Their Buy Rating on Stereotaxis (STXS)
Stereotaxis's Endovascular Robotic System Gains EU Clearance